Two new weight loss pills are now FDA-approved and available in the U.S. and if you are a woman searching for a daily pill alternative to weekly injections, this is the comparison you need before booking a doctor’s appointment.
Foundayo (orforglipron), made by Eli Lilly, was FDA-approved on April 1, 2026. The Wegovy pill (oral semaglutide), made by Novo Nordisk, was FDA-approved in December 2025. Both belong to the GLP-1 drug class the same family behind Ozempic, Wegovy injection, and Zepbound. But they work differently, have different dosing rules, different weight loss numbers, and carry women-specific concerns that most general health articles are not cover.
This guide breaks down everything: how they work, how much weight women can realistically lose, side effects, the critical birth control warning, cost, and who should choose which pill.
What Are Foundayo and the Wegovy Pill?
Both are once-daily oral GLP-1 receptor agonists. GLP-1 is a hormone your body naturally releases after eating to signal fullness, slow digestion, and regulate blood sugar. These pills mimic that hormone to reduce appetite and promote weight loss. That is the same mechanism used by the injectable drugs Ozempic, Wegovy, and Zepbound just in pill form.
Foundayo (Orforglipron) — Eli Lilly
- Active ingredient: Orforglipron — a small molecule, not a peptide
- Dosing: Once daily, any time of day, with or without food
- Doses available: 6 doses from 0.8 mg up to 17.2 mg
- FDA approved: April 1, 2026 — fastest new drug approval since 2002 (50 days)
- Manufacturer: Eli Lilly — same company as Zepbound and Mounjaro
Wegovy Pill (Oral Semaglutide) — Novo Nordisk
- Active ingredient: Semaglutide — the same peptide used in injectable Wegovy
- Dosing: Once daily, first thing in the morning ONLY on an empty stomach
- Food restriction: Must fast for 30 minutes after taking — water only allowed
- FDA approved: December 2025
- Manufacturer: Novo Nordisk — same company as injectable Wegovy and Ozempic
The biggest practical difference: Foundayo has zero food or timing restrictions. The Wegovy pill requires a strict morning fasting routine every single day to be absorbed properly.
How Much Weight Can Women Lose on Foundayo vs. the Wegovy Pill?
Clinical trial results give us the clearest comparison though it is important to note that these drugs were never tested head-to-head. The numbers come from separate trials with different populations.
Foundayo Weight Loss Results
In the ATTAIN clinical trial program reviewed by the FDA, participants taking the highest dose of Foundayo (17.2 mg) lost an average of 12.4% of their body weight over 72 weeks approximately 27 pounds. Across all doses in trials, average loss was about 25 pounds. Those taking a placebo lost an average of 2.2 pounds over the same period.
Wegovy Pill Weight Loss Results
The Wegovy pill showed higher average weight loss in clinical trials approximately 16 to 17% of starting body weight at the highest dose over 64 weeks. In one Phase 3 trial using a 25 mg dose, participants lost nearly 17% of their body weight. Those on placebo lost significantly less.
Important context: Injectable GLP-1 drugs produce significantly more weight loss Zepbound (tirzepatide) averages over 20% in trials. Both pills produce less than the injectables, but for women who prefer not to inject, a 12–17% reduction is clinically meaningful and can significantly improve blood pressure, blood sugar, and joint health.
Foundayo vs. Wegovy Pill: Full Comparison for Women
| Feature | Foundayo (Eli Lilly) | Wegovy Pill (Novo Nordisk) |
| Active Ingredient | Orforglipron (small molecule) | Oral semaglutide (peptide) |
| FDA Approved | April 1, 2026 | December 2025 |
| Avg. Weight Loss | ~12.4% of body weight | ~16–17% of body weight |
| Dosing Time | Any time of day | Morning only |
| Food Restriction | None — eat or fast, your choice | 30-min fast required after dose |
| Number of Doses | 6 doses (0.8 mg – 17.2 mg) | Multiple doses available |
| Self-Pay Price | $149–$349/month (by dose) | $149/month (lowest dose) |
| With Insurance | From $25/month | From $25/month |
| Medicare Part D | $50/mo from July 2026 | Not yet confirmed |
| Birth Control Warning | YES — discuss with doctor | Not prominently flagged |
| Hair Loss Side Effect | Yes — officially listed | Less commonly documented |
| Safety Data History | New molecule — newer data | 20+ years semaglutide class |
| Maintenance Use | Studied as step-down therapy | Primary treatment only |
| Best Use Case | Convenience, flexibility, maintain. | Maximum weight loss results |
What Women Specifically Need to Know Before Choosing
1. The Birth Control Warning — Read This Before You Start Foundayo
This is the most underreported women’s health issue in current Foundayo coverage, and it affects every woman on oral contraceptives.
2. Hair Loss — How Likely Is It and What Can You Do?
Hair loss is an officially listed side effect of Foundayo, and it is one of the most common reasons women stop GLP-1 medications. The medical term is telogen effluvium a temporary hair shedding triggered by rapid weight loss rather than the drug’s chemistry. It can occur with both Foundayo and the Wegovy pill.
To reduce the risk: maintain adequate protein intake (aim for 0.7 to 1 gram per pound of body weight daily), take a daily multivitamin with biotin and zinc, and avoid very aggressive calorie restriction alongside the medication. Hair loss is typically temporary and reverses as weight stabilizes.
3. PCOS — Can These Pills Help?
GLP-1 receptor agonists broadly improve insulin resistance, which is a root driver of polycystic ovary syndrome (PCOS) symptoms including weight gain, irregular periods, and elevated androgens. Foundayo has not yet been studied in a dedicated PCOS trial, but its mechanism is consistent with GLP-1 drugs that have shown benefit in PCOS populations. Women with PCOS should consult an endocrinologist or gynecologist before starting either pill.
4. Menopause and Perimenopause Weight Gain
Neither pill directly addresses the hormonal cause of menopausal weight gain declining estrogen levels. Both work by suppressing appetite and improving insulin sensitivity, which can help manage calorie intake during perimenopause. Women over 45 should treat these medications as one tool in a broader approach that also includes a conversation with their OB-GYN about hormone therapy options.
5. Pregnancy — Foundayo Is Not Safe
Foundayo’s safety during pregnancy has not been established. Women who become pregnant while taking it are encouraged to register with Eli Lilly’s Pregnancy Exposure Registry. Do not take Foundayo if you are pregnant, planning to become pregnant, or breastfeeding. Given the birth control interaction warning above, using a backup contraceptive method while on Foundayo is strongly advised.
Side Effects of Foundayo and Wegovy Pill in Women
Both pills share the same general GLP-1 side effect profile. Most side effects are gastrointestinal and occur in the first four to six weeks as the body adjusts to the medication.
Common Side Effects (Both Pills)
- Nausea — most common, typically improves after week 4–6
- Constipation and diarrhea
- Vomiting and indigestion
- Abdominal bloating, pain, and heartburn
- Fatigue and headache
- Gas and belching
- Hair loss — listed specifically for Foundayo; also occurs with rapid weight loss on Wegovy pill
Discontinuation Rates
In Foundayo clinical trials, 6 to 10% of participants stopped taking the drug due to gastrointestinal side effects, depending on the dose. For context, only 4% of those on placebo discontinued. Starting at the lowest dose and escalating slowly as the dosing schedule requires is the most effective way to minimize side effects.
Serious but Rare Risks
- Pancreatitis (inflammation of the pancreas)
- Acute kidney injury (from dehydration caused by GI side effects)
- Hypoglycemia (low blood sugar — particularly relevant for women with type 2 diabetes)
- Thyroid concerns (consistent with the broader GLP-1 drug class)
Note on safety data: The Wegovy pill (semaglutide) belongs to a drug class with over 20 years of human safety data. Foundayo uses a new small-molecule ingredient or forglipron with a shorter track record. Both the FDA and independent experts recommend continued monitoring as post-market safety data accumulates for Foundayo.
How Much Do Foundayo and the Wegovy Pill Cost for Women?
Both pills were priced at the same entry point as part of a deal between Eli Lilly, Novo Nordisk, and the U.S. government in late 2025 to make oral GLP-1 medications broadly accessible.
Self-Pay Pricing
- Foundayo: $149/month for the lowest dose (0.8 mg) up to $349/month at the highest doses
- Wegovy pill: $149/month for the lowest dose
- Both: Prices increase as you titrate to higher doses budget for the full escalation schedule
With Insurance or Savings Cards
- Commercial insurance + Eli Lilly savings card: As low as $25/month for Foundayo
- Commercial insurance + Novo Nordisk savings card: As low as $25/month for Wegovy pill
- Medicare Part D (Foundayo): $50/month starting July 2026 for women with BMI ≥35 or obesity plus a related health condition
- Telehealth platforms: Both pills are available via major telehealth providers often the fastest way to get a prescription
- LillyDirect: Foundayo available for home delivery from April 6, 2026
Which Pill Should You Choose? Foundayo or Wegovy Pill?
Choose Foundayo if you:
- Have an irregular schedule or cannot commit to a strict morning fasting routine
- Take multiple medications in the morning and need flexible dosing
- Have already hit your goal weight on an injectable GLP-1 and want a maintenance option
- Are on Medicare and want coverage (starting July 2026 at $50/month)
- Are trying a GLP-1 for the first time and want a gentle, flexible starting point
- Are not on oral birth control or have already discussed a backup method with your doctor
Choose the Wegovy Pill if you:
- Prioritize maximum weight loss 16–17% average vs 12.4% for Foundayo
- Are comfortable with a consistent morning fasting routine every day
- Have previously used injectable Wegovy or Ozempic and want to stay within the semaglutide family
- Prefer a medication backed by 20+ years of drug-class safety data
- Are on oral birth control and want to avoid the Foundayo interaction concern
Consider Injectable GLP-1s Instead if:
- You need more than 15–17% weight loss for serious health outcomes (heart disease, sleep apnea, severe metabolic conditions)
- Pills have not produced adequate results after 12–16 weeks at a therapeutic dose
- Your doctor recommends Zepbound (tirzepatide) for its dual GIP/GLP-1 action and stronger efficacy
FAQ About Foundayo and Wegovy Pill for Women
Q: Is Foundayo better than the Wegovy pill for women?
A: It depends on your priorities. The Wegovy pill produces higher average weight loss (16–17% vs 12.4%). Foundayo is significantly more convenient no food restrictions, any time of day. For women on birth control, Foundayo requires an important safety discussion with your doctor. Both cost $149/month at the lowest dose. Consult your doctor to match the right pill to your health goals and daily lifestyle.
Q: Can I take Foundayo if I am on birth control pills?
A: You must speak with your doctor before combining Foundayo with oral contraceptives. Foundayo may reduce the effectiveness of birth control pills, increasing the risk of unintended pregnancy. Eli Lilly recommends discussing the addition of a backup contraceptive method before starting. This concern does not apply to non-oral contraceptive methods such as the hormonal IUD, implant, patch, or ring.
Q: How much weight can women realistically lose on Foundayo?
A: In clinical trials, women and men on the highest dose of Foundayo lost an average of 12.4% of their body weight about 25 to 27 pounds over 72 weeks. Results require a reduced-calorie diet and increased physical activity alongside the medication. Some women will lose more; some less. Individual results depend on dose reached, adherence, dietary habits, and metabolic factors.
Q: Does Foundayo cause hair loss in women?
A: Yes, hair loss is an officially listed side effect of Foundayo. It is caused by telogen effluvium temporary shedding related to rapid weight loss rather than the drug’s chemistry. It can happen with both Foundayo and the Wegovy pill. To minimize it: eat adequate protein (0.7–1g per pound of body weight), take a multivitamin with biotin and zinc, and avoid very aggressive calorie restriction. Hair loss is typically temporary and reverses as weight stabilizes.
Q: Can I switch from injectable Wegovy or Zepbound to Foundayo?
A: Yes. Eli Lilly specifically studied this transition. Women who switched from injectable Wegovy to Foundayo regained an average of about 2 lbs, suggesting it works as an effective maintenance therapy. Women switching from Zepbound (which produces greater initial loss) regained an average of about 11 lbs after switching to Foundayo. Discuss this step-down strategy with your prescribing physician.
Q: Is Foundayo safe for women with PCOS?
A: Foundayo has not been studied specifically in PCOS populations, but its GLP-1 mechanism is consistent with drugs that have shown benefit for PCOS by improving insulin resistance. Women with PCOS should consult an endocrinologist or gynecologist before starting either pill PCOS involves hormonal complexity beyond weight alone.
Q: Which pill is easier to take daily — Foundayo or the Wegovy pill?
A: Foundayo is substantially more convenient. It can be taken at any time of day with or without food. The Wegovy pill must be taken first thing in the morning on a completely empty stomach with only a few sips of water, followed by a 30-minute fast before eating or drinking anything else. For working women, shift workers, mothers with hectic mornings, or anyone on complex medication schedules, Foundayo has a clear practical advantage.
Q: How much does Foundayo cost for women without insurance?
A: Foundayo starts at $149/month for the lowest dose (0.8 mg) for self-pay patients via LillyDirect. Higher doses range up to $349/month. With the Eli Lilly savings card and commercial insurance, eligible women may pay as little as $25/month. Medicare Part D coverage begins July 2026 at approximately $50/month for women with a BMI of 35 or higher or obesity with a related health condition.
Final Verdict: Foundayo vs. Wegovy Pill for Women
The Wegovy pill wins on raw weight loss results. Foundayo wins on daily convenience and flexibility. The right choice depends entirely on who you are and how you live.
- Want maximum weight loss? → Wegovy pill
- Want maximum daily convenience? → Foundayo
- On oral birth control? → Read the Foundayo interaction warning and discuss with your doctor first
- On Medicare? → Foundayo (coverage from July 2026)
- Just finished an injectable GLP-1? → Foundayo as a maintenance step-down
- Want a proven drug-class safety record? → Wegovy pill (semaglutide has 20+ years of data)
Neither pill replaces a healthy diet and consistent activity. Both require a prescription and medical supervision. Both carry real side effects that need to be managed. But for the millions of women who have avoided GLP-1 treatment because of needle anxiety, cost barriers, or access challenges having a daily pill option that works is a genuine and meaningful shift in what obesity treatment looks like.
Use this guide to walk into your doctor’s appointment informed. Ask specific questions. Bring up your birth control method. Mention any PCOS, thyroid, or hormonal history. The more context your doctor has, the better matched your prescription will be.
